
    
      The aim of this study will (1) evaluate the effect of 0.12% chlorhexidine gluconate on
      ventilator-associated pneumonia, ventilator-associated treakeabronchitis, (2) determine the
      effect of preventing microorganism colonization, and (3) assess the mortality rate for each
      patient and the cost-effectiveness in the health expenditures.
    
  